Direct-to-Consumer Laboratory Testing Market
Number of pages: 100 | Report Format: PDF | Published date: February 17, 2023
Historical Years – 2020 | Base Year – 2021 | Forecasted Years – 2022-2030
|
Report Attribute |
Details |
|
Market Size Value in 2021 |
US$ 2.78 billion |
|
Revenue Forecast in 2030 |
US$ 17.15 billion |
|
CAGR |
18.3% |
|
Base Year For Estimation |
2021 |
|
Forecast Period |
2022-2030 |
|
Historical Year |
2020 |
|
Segments Covered |
Sample type, Application, End User, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, and the Rest of the World (RoW) |
According to the deep-dive market assessment study by Growth Plus Reports, the global direct-to-consumer laboratory testing market was valued at US$ 2.78 billion in 2021 and is expected to register a revenue CAGR of 18.3% to reach US$ 17.15 billion by 2030.
Direct-to-consumer Laboratory Testing Market Fundamentals
Direct-to-consumer laboratory testing refers to medical tests that can be ordered by individuals directly, without the need for a doctor’s referral or prescription. Direct-to-consumer testing typically involves ordering laboratory tests online, receiving a test kit in the mail, collecting a sample at home, and sending it to a laboratory for analysis. Results are then made available to the individual through an online portal or other means.
Direct-to-consumer laboratory testing services are typically offered online and from the comfort of an individual’s home. These tests are often less expensive than tests ordered through a healthcare provider, making them a more affordable option for individuals who are paying for their own health. The results of direct-to-consumer laboratory tests can be accessed quickly, allowing individuals to make informed decisions about their health. Examples of direct-to-consumer laboratory tests include genetic testing, hormone testing, blood testing, saliva testing, microbiome testing, sexually transmitted diseases (STD) testing, and cancer screening.
[5765454]
Direct-to-consumer Laboratory Testing Market Dynamics
The rising prevalence of chronic diseases is the major factor in the revenue growth of the global direct-to-consumer laboratory testing market. For instance, according to a July 2022 report by the Centers for Disease Control and Prevention (CDC), about 6 in 10 adults from the United States suffer from chronic diseases, such as heart disease, cancer, and diabetes.
Direct-to-consumer laboratory testing allows customers to request tests online and obtain results without having to visit a doctor or medical facility. This might be especially tempting to people who want a quick and easy way to obtain health information. Additionally, technological advancements, such as the creation of mobile health (mHealth) platforms and the increased usage of wearable devices, have made it simpler for consumers to gain health information and request direct-to-consumer testing. These factors are fueling the global direct-to-consumer laboratory testing market revenue growth. Moreover, players in the direct-to-consumer laboratory testing industry are constantly extending their test offerings, increasing customer awareness, and access to these services, thus resulting in global market revenue growth.
However, misinterpretation of test findings, privacy issues with genetic data, and sample integrity are some of the restraints hampering the direct-to-consumer laboratory testing market revenue growth to some extent.
Direct-to-consumer Laboratory Testing Market Ecosystem
The global direct-to-consumer laboratory testing market is analyzed from four perspectives: sample type, application, end-user, and region.
Direct-to-consumer Laboratory Testing Market by Sample Type
[6546464]
Based on the sample type, the global direct-to-consumer laboratory testing market is segmented into saliva, urine, blood, nasopharyngeal, stool, and others.
The saliva segment accounted for the principal revenue share of the market in 2021, driven by the accuracy of results and the comfort it offers to patients. This segment’s growth indicates a growing trend among consumers seeking accessible, convenient, and cost-effective health information. The high accuracy and comfort level of saliva-based testing has been instrumental in attracting a large customer base, which has, in turn, led to significant revenue generation. Direct-to-consumer saliva testing is typically less expensive than testing ordered through a healthcare provider, which can make it a more affordable option for individuals who are paying for their own healthcare. These factors contribute to the revenue growth of the saliva segment.
Direct-to-consumer Laboratory Testing Market by Application
Based on the application, the global direct-to-consumer laboratory testing market is segmented into genetic testing, COVID-19, cancer, diabetes testing, disease testing, risk assessment testing, and others.
The genetic testing segment accounted for the principal revenue share of the market in 2021, attributed to learning about family health history and predictive testing, the introduction of new direct-to-consumer genetic tests for novel applications, and growing ancestry and genealogy interest among people in industrialized nations. Genetic testing is a process that analyzes a person’s DNA to identify changes or variations in their genetic code. These changes can provide information about a person’s risk of developing certain health conditions, their ancestry and heritage, and other aspects of their biology. Advances in DNA sequencing technology have made it easier and more affordable for consumers to access genetic testing services. Some consumers may prefer direct-to-consumer genetic testing as it allows them to keep their genetic information private and control who has access to it. Direct-to-consumer genetic testing is typically less expensive than genetic testing ordered through a healthcare provider, which can make it a more inexpensive option for people who are paying for their own healthcare.
Direct-to-consumer Laboratory Testing Market by End-user
Based on the end-user, the global direct-to-consumer laboratory testing market is segmented into hospitals, diagnostics centers, and reference laboratories.
The diagnostics centers segment dominated the market with the largest revenue share in 2021, owing to the increased demand for diagnostic services as consumers seek out more convenient and accessible ways to obtain health information. Direct-to-consumer diagnostic centers offer a range of tests that can be ordered easily and conveniently. They often offer testing services at a lower cost than traditional hospitals. Direct-to-consumer diagnostic centers have improved accessibility by offering a wide range of tests that can be ordered remotely and performed locally, making it easier for consumers to access testing services. These overarching variables contribute to the diagnostics centers segment revenue growth.
Direct-to-consumer Laboratory Testing Market by Region
Geographically, the global direct-to-consumer laboratory testing market has been segmented into North America, Europe, Asia Pacific, and the rest of the world.
North America dominated the global direct-to-consumer laboratory testing market with the largest revenue share in 2021, owing to the increased incidence of infectious and chronic diseases, as well as growth in public awareness of disease risk prediction and healthy living. Additionally, the rising focus of companies in the region on partnerships, mergers, and acquisitions is helping the market’s revenue growth in the region. For instance, in November 2022, 1health.io Inc., an industry-leading software company that enables diagnostic laboratories to expand their testing rapidly and securely in both clinical and direct-to-consumer markets, partnered with Apollo Health Group to bring Apollo’s specialized high-performing NGS tests, such as hereditary cancer genetic screenings (CGx) and pharmacogenetics screenings (PGx), to the broader clinical market. Using 1health’s online portal, physicians from anywhere in the United States may sign up and make orders digitally and securely, and test results can be processed swiftly and safely.
Direct-to-consumer Laboratory Testing Market Competitive Landscape
The prominent players operating in the global direct-to-consumer laboratory testing market are:
Direct-to-consumer Laboratory Testing Market Strategic Developments
The global direct-to-consumer laboratory testing market is estimated to be valued at US$ 17.15 billion by 2030.
The direct-to-consumer laboratory testing market is expected to register a revenue CAGR of 18.3% during the forecast period from 2022 to 2030.
The rising prevalence of chronic diseases, technological advancements, and increasing focus of firms on constantly extending their test offerings are driving revenue growth in the global direct-to-consumer laboratory testing market.
The saliva segment dominates the direct-to-consumer laboratory testing market.
Laboratory Corporation of America Holdings, Color Health, Inc., Dante Labs Inc., Quest Diagnostics, and WellnessFx are among the top market players.
*Insights on financial performance are subject to the availability of information in the public domain